OBJECTIVES: To evaluate the mental health burden in rheumatoid arthritis (RA) and axial spondyloarthritis (axSpA) using diagnostic and self-reported tools and to examine its associations with current disease activity, patient-reported outcomes and barriers to appropriate care. DESIGN: Single-centre, cross-sectional, case-control study. SETTING: Rheumatology centre of a tertiary care hospital, serving as a referral clinic with outpatient and inpatient care in Czech Republic. PARTICIPANTS: 233 patients with rheumatic diseases (113 RA, 120 axSpA) and 170 healthy controls (HC). OUTCOME MEASURES: Mental disorders (MD) were assessed through a structured psychiatric interview using the International Neuropsychiatric Interview (Mini International Neuropsychiatric Interview) administered by a trained professional and by self-reported questionnaires including the Beck Depression Inventory-II (BDI-II) and Beck Anxiety Inventory (BAI). Disease activity was evaluated with the Disease Activity Score-28 with C-reactive protein (DAS28-CRP) for RA and the Ankylosing Spondylitis Disease Activity Score with CRP (ASDAS-CRP) for axSpA, alongside patient-reported outcomes (PROs). RESULTS: At least one MD was present in 24.8% of RA, 31.7% of axSpA and 7.0% of HC (p<0.001), driven mainly by major depression, dysthymia and suicidal ideation. Thresholds for depression and anxiety were significantly more frequent in RA and axSpA than HC (BDI-II: 18.6% vs 4.0% and 17.5% vs 1.7%; BAI: 38.9% vs 13.9% and 26.7% vs 11.0%; all p<0.001). Patients with MD had higher disease activity (RA: DAS28-CRP 3.12 vs 2.68, p<0.05; axSpA: ASDAS-CRP 2.39 vs 1.63, p<0.001). The presence of MD was associated with an increase of 0.40 in DAS28-CRP and 0.24 in ASDAS-CRP, although a 10-point increase in BDI-II was required for a similar association. Most patients with MD (75.0% RA, 89.6% axSpA) declined psychiatric counselling despite poorer concurrent outcomes in disease activity and PROs. CONCLUSIONS: Mental disorders in RA and axSpA are closely associated with higher disease activity and unfavourable PROs, while access to and acceptance of psychiatric care remain markedly insufficient. Systematic integration of mental health assessment and management into rheumatology practice is strongly warranted.

1st Faculty of Medicine Charles University and Rheumatology Institute Na Slupi 4 Prague Czech Republic

3rd Faculty of Medicine Charles University Prague Czech Republic

Clinical Center National Institute of Mental Health Klecany Czech Republic

Department of Public Mental Health National Institute of Mental Health Klecany Czech Republic

Health Monk s r o Prague Czech Republic

Zobrazit více v PubMed

Solomon DH, Guan H, Johansson FD, et al. Assessing clusters of comorbidities in rheumatoid arthritis: a machine learning approach. Arthritis Res Ther. 2023;25:224. doi: 10.1186/s13075-023-03191-8. PubMed DOI PMC

Bosch P, Zhao SS, Nikiphorou E. The association between comorbidities and disease activity in spondyloarthritis - A narrative review. Best Pract Res Clin Rheumatol. 2023;37:101857. doi: 10.1016/j.berh.2023.101857. PubMed DOI

Dougados M, Soubrier M, Antunez A, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA) Ann Rheum Dis. 2014;73:62–8. doi: 10.1136/annrheumdis-2013-204223. PubMed DOI PMC

Zhao SS, Robertson S, Reich T, et al. Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis. Rheumatology (Oxford) 2020;59:iv47–57. doi: 10.1093/rheumatology/keaa246. PubMed DOI PMC

Zhao S, Thong D, Miller N, et al. The prevalence of depression in axial spondyloarthritis and its association with disease activity: a systematic review and meta-analysis. Arthritis Res Ther. 2018;20:140. doi: 10.1186/s13075-018-1644-6. PubMed DOI PMC

Brock J, Basu N, Schlachetzki JCM, et al. Immune mechanisms of depression in rheumatoid arthritis. Nat Rev Rheumatol. 2023;19:790–804. doi: 10.1038/s41584-023-01037-w. PubMed DOI

Matcham F, Ali S, Irving K, et al. Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study. BMC Musculoskelet Disord. 2016;17:155. doi: 10.1186/s12891-016-1011-1. PubMed DOI PMC

Fragoulis GE, Cavanagh J, Tindell A, et al. Depression and anxiety in an early rheumatoid arthritis inception cohort. associations with demographic, socioeconomic and disease features. RMD Open. 2020;6:e001376. doi: 10.1136/rmdopen-2020-001376. PubMed DOI PMC

Sautner J, Puchner R, Alkin A, et al. Depression: a common comorbidity in women with rheumatoid arthritis-results from an Austrian cross-sectional study. BMJ Open. 2020;10:e033958. doi: 10.1136/bmjopen-2019-033958. PubMed DOI PMC

Sweeney M, Adas MA, Cope A, et al. Longitudinal effects of affective distress on disease outcomes in rheumatoid arthritis: a meta-analysis and systematic review. Rheumatol Int. 2024;44:1421–33. doi: 10.1007/s00296-024-05574-9. PubMed DOI PMC

Snoeck Henkemans SVJ, Vis M, Koc GH, et al. Association between depression and anxiety and inability to achieve remission in rheumatoid arthritis and psoriatic arthritis. Rheumatology (Oxford) 2025;64:2411–21. doi: 10.1093/rheumatology/keae621. PubMed DOI PMC

Robinson PC, van der Linden S, Khan MA, et al. Axial spondyloarthritis: concept, construct, classification and implications for therapy. Nat Rev Rheumatol. 2021;17:109–18. doi: 10.1038/s41584-020-00552-4. PubMed DOI

Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68:777–83. doi: 10.1136/ard.2009.108233. PubMed DOI

López-Medina C, Ramiro S, van der Heijde D, et al. Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: a comparison by systematic literature review and meta-analysis. RMD Open. 2019;5:e001108. doi: 10.1136/rmdopen-2019-001108. PubMed DOI PMC

Sundquist K, Li X, Hemminki K, et al. Subsequent risk of hospitalization for neuropsychiatric disorders in patients with rheumatic diseases: a nationwide study from Sweden. Arch Gen Psychiatry. 2008;65:501–7. doi: 10.1001/archpsyc.65.5.501. PubMed DOI

Omar M, Ben-Shabat N, Tsur AM, et al. The association between ankylosing spondylitis and psychiatric disorders: Insights from a population based cross-sectional database. J Affect Disord. 2023;323:788–92.:S0165-0327(22)01385-4. doi: 10.1016/j.jad.2022.12.024. PubMed DOI

Chan CYY, Tsang HHL, Lau CS, et al. Prevalence of depressive and anxiety disorders and validation of the Hospital Anxiety and Depression Scale as a screening tool in axial spondyloarthritis patients. Int J Rheum Dis. 2017;20:317–25. doi: 10.1111/1756-185X.12456. PubMed DOI

Reich A, Weiß A, Lindner L, et al. Effect of depressive symptoms on treatment response in patients with axSpA: data from the RABBIT-SpA register. RMD Open. 2025;11:e005422. doi: 10.1136/rmdopen-2025-005422. PubMed DOI PMC

von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. Ann Intern Med. 2007;147:573–7. doi: 10.7326/0003-4819-147-8-200710160-00010. PubMed DOI

Redeker I, Callhoff J, Hoffmann F, et al. The prevalence and impact of comorbidities on patients with axial spondyloarthritis: results from a nationwide population-based study. Arthritis Res Ther. 2020;22:210. doi: 10.1186/s13075-020-02301-0. PubMed DOI PMC

Formánek T, Kagström A, Cermakova P, et al. Prevalence of mental disorders and associated disability: Results from the cross-sectional CZEch mental health Study (CZEMS) Eur Psychiatry. 2019;60:1–6.:S0924-9338(19)30082-3. doi: 10.1016/j.eurpsy.2019.05.001. PubMed DOI

Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24. doi: 10.1002/art.1780310302. PubMed DOI

Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580–8. doi: 10.1136/ard.2010.138461. PubMed DOI

Sieper J, Rudwaleit M, Baraliakos X, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009;68 Suppl 2:ii1–44. doi: 10.1136/ard.2008.104018. PubMed DOI

Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33:337–43. doi: 10.3109/07853890109002087. PubMed DOI

Pincus T, Summey JA, Soraci SA, Jr, et al. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum. 1983;26:1346–53. doi: 10.1002/art.1780261107. PubMed DOI

Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22–33. PubMed

Pettersson A, Modin S, Wahlström R, et al. The Mini-International Neuropsychiatric Interview is useful and well accepted as part of the clinical assessment for depression and anxiety in primary care: a mixed-methods study. BMC Fam Pract. 2018;19:19. doi: 10.1186/s12875-017-0674-5. PubMed DOI PMC

Ptáček R, et al. Beck Depression inventory BDI-II – standardization and its use in practice. Česká a Slovenská Psychiatrie. 2016;112:270–4.

Kamaradova D, Prasko J, Latalova K, et al. Psychometric properties of the Czech version of the Beck Anxiety Inventory - comparison between diagnostic groups. Neuro Endocrinol Lett. 2015;36:706–12. PubMed

Beck AT, Epstein N, Brown G, et al. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893–7. doi: 10.1037//0022-006x.56.6.893. PubMed DOI

Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77–100. doi: 10.1016/0272-7358(88)90050-5. DOI

Julian LJ. Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A) Arthritis Care Res (Hoboken) 2011;63 Suppl 11:S467–72. doi: 10.1002/acr.20561. PubMed DOI PMC

Ebrahimi Kalan M, Jebai R, Zarafshan E, et al. Distinction Between Two Statistical Terms: Multivariable and Multivariate Logistic Regression. Nicotine Tob Res. 2021;23:1446–7. doi: 10.1093/ntr/ntaa055. PubMed DOI

Pedregosa F, et al. Scikit-learn: Machine Learning in Python. J Mach Learn Res. 2012:12.

Seabold S, Perktold J. Statsmodels: econometric and statistical modeling with python. Python in Science Conference; Austin, Texas. 2010. DOI

Harris CR, Millman KJ, van der Walt SJ, et al. Array programming with NumPy. Nature New Biol. 2020;585:357–62. doi: 10.1038/s41586-020-2649-2. PubMed DOI PMC

Guo S, Qing G, Yang G. The relationship between chronic disease variety and quantity and suicidal ideation: A cross-sectional study of NHANES. J Psychosom Res. 2024;184:111854. doi: 10.1016/j.jpsychores.2024.111854. PubMed DOI

Wu JJ, Penfold RB, Primatesta P, et al. The risk of depression, suicidal ideation and suicide attempt in patients with psoriasis, psoriatic arthritis or ankylosing spondylitis. J Eur Acad Dermatol Venereol. 2017;31:1168–75. doi: 10.1111/jdv.14175. PubMed DOI

Marrie RA, Walld R, Bolton JM, et al. Psychiatric comorbidity increases mortality in immune-mediated inflammatory diseases. Gen Hosp Psychiatry. 2018;53:65–72. doi: 10.1016/j.genhosppsych.2018.06.001. PubMed DOI

Shen C-C, Hu L-Y, Yang AC, et al. Risk of Psychiatric Disorders following Ankylosing Spondylitis: A Nationwide Population-based Retrospective Cohort Study. J Rheumatol. 2016;43:625–31. doi: 10.3899/jrheum.150388. PubMed DOI

Karmacharya P, Crowson CS, Lennon RJ, et al. Multimorbidity phenotypes in ankylosing spondylitis and their association with disease activity and functional impairment: Data from the prospective study of outcomes in ankylosing spondylitis cohort. Semin Arthritis Rheum. 2024;64:152282. doi: 10.1016/j.semarthrit.2023.152282. PubMed DOI PMC

Callhoff J, Berger K, Albrecht K, et al. Depression, anxiety and cognitive function in persons with inflammatory rheumatic diseases: cross-sectional results from the German National Cohort (NAKO) RMD Open. 2024;10:e004808. doi: 10.1136/rmdopen-2024-004808. PubMed DOI PMC

Creed F. Psychiatric disorders comorbid with general medical illnesses and functional somatic disorders: The Lifelines cohort study. PLoS One. 2023;18:e0286410. doi: 10.1371/journal.pone.0286410. PubMed DOI PMC

Khan AK, Nabi J, Parrey AH, et al. Patterns and prevalence of psychiatric morbidity among individuals with rheumatoid arthritis. Reumatologia. 2024;62:115–20. doi: 10.5114/reum/186975. PubMed DOI PMC

Pezzato S, Bonetto C, Caimmi C, et al. Depression is associated with increased disease activity and higher disability in a large Italian cohort of patients with rheumatoid arthritis. Adv Rheumatol . 2021;61:57. doi: 10.1186/s42358-021-00214-3. PubMed DOI

Zhao SS, Radner H, Siebert S, et al. Comorbidity burden in axial spondyloarthritis: a cluster analysis. Rheumatology (Oxford) 2019;58:1746–54. doi: 10.1093/rheumatology/kez119. PubMed DOI PMC

Alp G, Cinakli H, Kurut Aysin İ, et al. Challenges and insights in managing difficult-to-treat rheumatoid arthritis: real-world clinical perspectives. Clin Exp Rheumatol. 2024;42:1398–406. doi: 10.55563/clinexprheumatol/nyu9er. PubMed DOI

Ramiro S, Nikiphorou E, Sepriano A, et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis. 2023;82:19–34. doi: 10.1136/ard-2022-223296. PubMed DOI

Yin Y, Ju T, Zeng D, et al. “Inflamed” depression: A review of the interactions between depression and inflammation and current anti-inflammatory strategies for depression. Pharmacol Res. 2024;207:107322. doi: 10.1016/j.phrs.2024.107322. PubMed DOI

Beurel E, Toups M, Nemeroff CB. The Bidirectional Relationship of Depression and Inflammation: Double Trouble. Neuron. 2020;107:234–56. doi: 10.1016/j.neuron.2020.06.002. PubMed DOI PMC

Hinch R, Sirois FM. A meta-analysis of coping strategies and psychological distress in rheumatoid arthritis. Br J Health Psychol. 2024;29:771–87. doi: 10.1111/bjhp.12726. PubMed DOI

Wang RAH, Smittenaar P, Thomas T, et al. Geographical variation in perceptions, attitudes and barriers to mental health care-seeking across the UK: a cross-sectional study. BMJ Open. 2024;14:e073731. doi: 10.1136/bmjopen-2023-073731. PubMed DOI PMC

Fawole OA, Reed MV, Harris JG, et al. Engaging patients and parents to improve mental health intervention for youth with rheumatological disease. Pediatr Rheumatol Online J. 2021;19:19. doi: 10.1186/s12969-021-00503-7. PubMed DOI PMC